Rossari Biotech approves capacity expansions at key subsidiaries

Rossari Biotech Limited has announced approved capacity expansions at its two material subsidiaries—Unitop Chemicals Pvt Ltd and Tristar Intermediates Pvt Ltd—as part of its strategic growth plans. The decisions were taken at respective board meetings held on April 24, 2025.

Unitop Chemicals Pvt Ltd will add 18,500 MTPA of new capacity in a phased manner, targeted for completion by fourth quarter of fiscal 2026 (Q4 FY 2025–26). The project involves an investment of ₹77 crore (~$9.24 million), funded through a combination of internal accruals and debt.

The expansion aims to support the launch of new product lines, strengthen market responsiveness, and enhance competitiveness in both domestic and international markets, the company said in an NSE listing.

Tristar Intermediates Pvt Ltd, meanwhile, will add 3,600 MTPA to its existing capacity of 15,000 MTPA—currently operating at 90 per cent utilization. The ₹20 crore (~$2.4 million) investment, also financed through internal accruals and debt, will be used to upgrade existing equipment with modern technology, thereby improving energy efficiency, product consistency, and process safety while reducing maintenance costs over time. The commissioning is expected by Q4 FY 2025–26.

ALCHEMPro News Desk (HU)